Immortalization of primary human prostate epithelial cells by c-Myc
- PMID: 15781629
- DOI: 10.1158/0008-5472.CAN-03-4030
Immortalization of primary human prostate epithelial cells by c-Myc
Erratum in
-
Editor's Note: Immortalization of Primary Human Prostate Epithelial Cells by c-Myc.Cancer Res. 2022 Jul 18;82(14):2656. doi: 10.1158/0008-5472.CAN-22-1588. Cancer Res. 2022. PMID: 35844174 No abstract available.
Abstract
A significant percentage of prostate tumors have amplifications of the c-Myc gene, but the precise role of c-Myc in prostate cancer is not fully understood. Immortalization of human epithelial cells involves both inactivation of the Rb/p16INK4a pathway and telomere maintenance, and it has been recapitulated in culture by expression of the catalytic subunit of telomerase, hTERT, in combination with viral oncoproteins. Here, we show the immortalization of human prostate epithelial cells (HPrEC) by a single genetic event, the expression of the c-Myc oncogene. Myc stabilizes telomere length in HPrEC through up-regulation of hTERT expression and overrides the accumulation of cell cycle inhibitory proteins, such as p16INK4a. Overall, HPrECs expressing c-Myc retain many characteristics of normal cells, such as the induction of a senescence-like growth arrest in response to oncogenic Ras, an intact p53 response, and an absence of gross karyotypic abnormalities. However, HPrECs expressing c-Myc lack a Rb/p16INK4a checkpoint and can be transformed without the need for additional genetic lesions in that pathway. These results give a partial explanation for the physiologic role of c-Myc overexpression in prostate cancer.
Similar articles
-
Prostate epithelial cell of origin determines cancer differentiation state in an organoid transformation assay.Proc Natl Acad Sci U S A. 2016 Apr 19;113(16):4482-7. doi: 10.1073/pnas.1603645113. Epub 2016 Apr 4. Proc Natl Acad Sci U S A. 2016. PMID: 27044116 Free PMC article.
-
N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells.Cancer Cell. 2016 Apr 11;29(4):536-547. doi: 10.1016/j.ccell.2016.03.001. Epub 2016 Mar 31. Cancer Cell. 2016. PMID: 27050099 Free PMC article.
-
Telomerase activation by c-Myc in human mammary epithelial cells requires additional genomic changes.Cell Cycle. 2009 Oct 15;8(20):3373-8. doi: 10.4161/cc.8.20.9856. Epub 2009 Oct 19. Cell Cycle. 2009. PMID: 19806010
-
Telomeres, telomerase, and myc. An update.Mutat Res. 2000 Jan;462(1):31-47. doi: 10.1016/s1383-5742(99)00091-5. Mutat Res. 2000. PMID: 10648922 Review.
-
Telomerase activation, cellular immortalization and cancer.Ann Med. 2001 Mar;33(2):123-9. doi: 10.3109/07853890109002067. Ann Med. 2001. PMID: 11327115 Review.
Cited by
-
ZNFX1 anti-sense RNA 1 promotes the tumorigenesis of prostate cancer by regulating c-Myc expression via a regulatory network of competing endogenous RNAs.Cell Mol Life Sci. 2020 Mar;77(6):1135-1152. doi: 10.1007/s00018-019-03226-x. Epub 2019 Jul 18. Cell Mol Life Sci. 2020. PMID: 31321444 Free PMC article.
-
MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells.PLoS One. 2010 Feb 25;5(2):e9427. doi: 10.1371/journal.pone.0009427. PLoS One. 2010. PMID: 20195545 Free PMC article.
-
Transformation of human and murine fibroblasts without viral oncoproteins.Mol Cell Biol. 2005 Aug;25(15):6464-74. doi: 10.1128/MCB.25.15.6464-6474.2005. Mol Cell Biol. 2005. PMID: 16024784 Free PMC article.
-
miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cells.Oncotarget. 2016 Aug 30;7(35):56628-56642. doi: 10.18632/oncotarget.10652. Oncotarget. 2016. PMID: 27447749 Free PMC article.
-
Prostate-specific oncogene OTUD6A promotes prostatic tumorigenesis via deubiquitinating and stabilizing c-Myc.Cell Death Differ. 2022 Sep;29(9):1730-1743. doi: 10.1038/s41418-022-00960-x. Epub 2022 Feb 25. Cell Death Differ. 2022. PMID: 35217790 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous